Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Alyeska Investment Group, L.P. SATL Satellogic Inc. 13G/A 0.04% 6mo
Portolan Capital Management, LLC REAX Real REMAX Group Inc. 13G/A 6.8% 6mo
T. Rowe Price Investment Management, Inc. DCOM Dime Commercial Bancshares, Inc. 13G/A 4.5% 6mo
WELLINGTON MANAGEMENT GROUP LLP JCAP Jefferson Capital, Inc. 13G 5.9% 6mo
AMERIPRISE FINANCIAL INC FVRR Fiverr International Ltd. 13G/A 8.5% 6mo
ARMISTICE CAPITAL, LLC SGMOQ Sangamo Therapeutics, Inc 13G 9.75% 6mo
CANADA PENSION PLAN INVESTMENT BOARD SM SM Energy Co 13G/A 6.1% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ VMRK Vivmark Residential 13G/A 4.8% 6mo
T. Rowe Price Investment Management, Inc. ERAS Erasca, Inc. 13G/A 6.8% 6mo
Cinctive Capital Management LP LZM Lifezone Metals Ltd 13G/A 11.8% 6mo
Orbis Investment Management Limited DAO Youdao, Inc. 13G/A 21.5% 6mo
Fort Baker Capital Management LP EGHA EGH Acquisition Corp. 13G 6% 6mo
AMERIPRISE FINANCIAL INC SYNA SYNAPTICS Inc 13G/A 19.5% 6mo
Alyeska Investment Group, L.P. SOC Sable Offshore Corp. 13G/A 1.83% 6mo
HARRIS ASSOCIATES L P CNH CNH Industrial N.V. 13G/A 4.7% 6mo
Almitas Capital LLC ANTX AN2 Therapeutics, Inc. 13G/A 4.1% 6mo
RA CAPITAL MANAGEMENT, L.P. PCVX Vaxcyte, Inc. 13G/A 8.9% 6mo
Chun Yen Lim GIBO GIBO HOLDINGS Ltd 13G/A 3.6% 6mo
Cormorant Asset Management, LP MLTX MoonLake Immunotherapeutics 13G/A 6.25% 6mo
T. Rowe Price Investment Management, Inc. BDX Becton Dickinson & Co 13G/A 3.4% 6mo
WELLINGTON MANAGEMENT GROUP LLP MBWM Mercantile Bank Corp 13G 6.9% 6mo
Polar Asset Management Partners Inc. QADR QDRO Acquisition Corp. 13G 7.5% 6mo
EcoR1 Capital, LLC IBIO iBio, Inc. 13G/A 4.6% 6mo
Brian Venturo CRWV CoreWeave, Inc. 13G/A 6.2% 6mo
METEORA CAPITAL, LLC FAC Factorial Energy Inc. 13G 5.4% 6mo
ARMISTICE CAPITAL, LLC RKDA Arcadia Biosciences, Inc. 13G 7.75% 6mo
Longitude Capital Partners II, LLC RPID Rapid Micro Biosystems, Inc. 13G/A 8.6% 6mo
Jacob Suen AIRG Airgain Inc 13G/A 6.6% 6mo
Iroquois Capital Management, LLC FABC Fabric.AI, Inc. 13G/A 9.99% 6mo
ADAR1 Capital Management, LLC LONA LeonaBio, Inc. 13G 7.7% 6mo
Portolan Capital Management, LLC FORR Forrester Research, Inc. 13G/A 7.94% 6mo
COOPER CREEK PARTNERS MANAGEMENT LLC WW Ww International, Inc. 13G/A 9.8% 6mo
K2 HealthVentures Equity Trust LLC NMRA Neumora Therapeutics, Inc. 13G/A 3.1% 6mo
WELLINGTON MANAGEMENT GROUP LLP NWFL Norwood Financial Corp 13G/A 6.9% 6mo
Balyasny Asset Management L.P. TALK Talkspace, Inc. 13G 5.31% 6mo
Sirenia Capital Management LP ANRO Alto Neuroscience, Inc. 13G 7.9% 6mo
ARMISTICE CAPITAL, LLC VVOS Vivos Therapeutics, Inc. 13G 8.27% 6mo
Polar Asset Management Partners Inc. KDK Kodiak AI, Inc. 13G/A 1.3% 6mo
LMR Partners LLP SVIA Silvia, Inc. 13G 5.8% 6mo
WELLINGTON MANAGEMENT GROUP LLP PECO Phillips Edison & Company, Inc. 13G/A 4.1% 6mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC FBIO Fortress Biotech, Inc. 13G/A 7.8% 6mo
WELLINGTON MANAGEMENT GROUP LLP EFSC Enterprise Financial Services Corp 13G/A 8.8% 6mo
Pencross Energy, LLC FRMI Fermi Inc. 13G/A 4.5% 6mo
T. Rowe Price Investment Management, Inc. IMNM Immunome Inc. 13G/A 14.5% 6mo
Manulife Investment Management (US) LLC CZWI Citizens Community Bancorp Inc. 13G/A 5.01% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ ORIC Oric Pharmaceuticals, Inc. 13G 5.4% 6mo
Nantahala Capital Management, LLC SRZN Surrozen, Inc. 13G/A 2.14% 6mo
WELLINGTON MANAGEMENT GROUP LLP ALHC Alignment Healthcare, Inc. 13G/A 8.4% 6mo
BAMCO INC /NY/ MTN Vail Resorts Inc 13G/A 14.15% 6mo
METEORA CAPITAL, LLC HCMA Hcm III Acquisition Corp. 13G 8.2% 6mo